Labcorp Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Labcorp Holdings şirketinin kazançları yıllık ortalama -12% oranında azalırken, Healthcare sektörünün kazançları yıllık 5.4% oranında artan oldu. Gelirler yıllık ortalama 0.6% oranında azalan oldu. Labcorp Holdings şirketinin öz sermaye getirisi 5.3% olup, net marjı 3.4% dir.

Anahtar bilgiler

-12.0%

Kazanç büyüme oranı

-10.2%

EPS büyüme oranı

Healthcare Sektör Büyümesi8.5%
Gelir büyüme oranı-0.6%
Özkaynak getirisi5.3%
Net Marj3.4%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

Oct 19
Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Sep 12
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability

Sep 11

Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Jul 20
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Laboratory Corporation: Limited Upside Visibility, Reiterate Hold

Jun 21

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Jun 13
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

May 08
Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Apr 30
Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Apr 15
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Apr 06
Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear

Apr 01

Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

Feb 25
Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Feb 21
An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Jan 31
Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Jan 30
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Jan 15
Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Jan 05
Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Laboratory Corporation: Multiple Updates, Same Investment Conclusion

Dec 02

Laboratory Corp.: Rate On Capital Deployed Contracting, Hold

Sep 14

Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea

Jul 05

Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts

Jul 04
Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts

Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?

Jun 23
Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?

Laboratory Corporation: Predictability Of Cash Flows Less Visible

Jun 21

Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

May 26
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Mar 16
Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Mar 02
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Gelir ve Gider Dağılımı

Labcorp Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NYSE:LH Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2412,7134362,1790
30 Jun 2412,4884502,1360
31 Mar 2412,3003992,0840
31 Dec 2312,1623792,0320
30 Sep 2312,0585831,9440
30 Jun 2311,8686771,8720
31 Mar 2311,7577891,7980
31 Dec 2211,8641,0021,7630
30 Sep 2212,9901,5181,8510
30 Jun 2214,1861,8291,9180
31 Mar 2215,1042,0281,9440
31 Dec 2113,1362,1951,6900
30 Sep 2116,5552,7631,8940
30 Jun 2116,3882,8791,7870
31 Mar 2115,3162,6431,7180
31 Dec 2013,9791,5561,7290
30 Sep 2012,4428451,5500
30 Jun 2011,4753621,5350
31 Mar 2011,5873211,5230
31 Dec 1911,5558241,6250
30 Sep 1911,3897551,5210
30 Jun 1911,2928531,4960
31 Mar 1911,2768961,4900
31 Dec 1811,3338841,5780
30 Sep 1811,2911,4141,5040
30 Jun 1811,0811,2661,4830
31 Mar 1810,7431,2171,4580
31 Dec 1710,3081,2271,4990
30 Sep 179,9517241,4360
30 Jun 179,7027321,4710
31 Mar 179,5567511,5220
31 Dec 169,5537121,3060
30 Sep 169,2956581,5920
30 Jun 169,1926331,6520
31 Mar 169,0295991,5560
31 Dec 158,5064381,4690
30 Sep 157,7744471,3600
30 Jun 157,0564301,2130
31 Mar 156,3534011,2040
31 Dec 146,0125111,1810
30 Sep 145,9365181,1640
30 Jun 145,8465291,1430
31 Mar 145,7985401,1310
31 Dec 135,8085741,1290

Kaliteli Kazançlar: LH büyük bir tek seferlik zarar ile $477.1M, 30th September, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: LH 'nin mevcut net kar marjları (3.4%) geçen yılın (4.8%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: LH şirketinin kazançları son 5 yılda yılda 12% oranında azaldı.

Büyüme Hızlandırma: LH 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: LH geçtiğimiz yıl negatif kazanç büyümesine ( -25.3% ) sahipti ve bu da onu Healthcare sektör ortalamasıyla ( 11.4% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: LH 'nin Özsermaye Getirisi ( 5.3% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin